Zepbound Clinics Near Me - FDA-Approved Weight Loss with Tirzepatide

What Is Zepbound?

Zepbound is the brand name for tirzepatide 2.5mg-15mg weekly injection, FDA-approved in November 2023 specifically for chronic weight management in adults with obesity or overweight with a weight-related health condition. It contains the same active ingredient as Mounjaro but is approved for weight loss rather than diabetes.

Zepbound is currently the most effective FDA-approved weight loss medication available. In the SURMOUNT-1 trial, patients lost an average of 20.9% of their body weight at the highest dose (15mg) over 72 weeks - roughly 48 pounds for a 230-pound person. This substantially exceeds the results achieved with Wegovy (semaglutide 2.4mg), which produces approximately 15% weight loss.

Zepbound works by activating both GIP and GLP-1 receptors simultaneously - the dual mechanism produces greater appetite suppression and metabolic improvement than single-agonist drugs. It requires a physician prescription and weekly subcutaneous injection.

Who Considers Zepbound?

• Adults with obesity (BMI 30+) seeking the most effective FDA-approved weight loss injection
• Overweight adults (BMI 27+) with a weight-related condition who want maximum efficacy
• People who tried Wegovy or semaglutide but want greater results
• Those who want an evidence-based, physician-supervised weight management program with the strongest available data

What to Expect at a Consultation

A Zepbound consultation will assess your BMI, weight history, any weight-related health conditions, and weight management goals. Your physician will confirm you meet the FDA indication and walk through the titration schedule: starting at 2.5mg weekly and increasing in 2.5mg increments every 4 weeks to 10mg or 15mg. Most telehealth clinics can prescribe Zepbound following an initial consultation, with medication available at your local pharmacy or via mail order. Follow-ups track weight progress, side effects, and any metabolic markers.